Validating Utility of 2018 ESC/EACTS Guideline-Endorsed High Ischemic Risk Features for Prediction of Clinical Outcomes in an Unrestricted Percutaneous Coronary Intervention Population with Drug-Eluting Stents
Complex and Higher Risk Procedures for Indicated Patients (CHIP)